Tharimmune Inc Com Gains 64.87%
Tharimmune Inc Com (THAR:NASDAQ) rocketted at $0.26, a gain of 64.9%. On Tue, Nov 07, 2023, THAR:NASDAQ touched a New 2-Week High of $0.26. The stock got featured on our News Catalysts scanner on Tue, Nov 07, 2023 at 04:50 AM in the 'AGREEMENT' category. From Wed, Oct 25, 2023, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Tue, Oct 24, 2023 at $0.38 with a volume of 20M+.
About Tharimmune Inc Com (THAR:NASDAQ)
Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for...
Top 10 Gainers:
- Tempo Automation Holdings Inc. (TMPO:NASDAQ), 250%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 102.94%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 78.08%
- Jaguar Global Growth Corporation I (JGGC:NASDAQ), 69.64%
- Vinco Ventures Inc. (BBIG:NASDAQ), 66.67%
- Tharimmune Inc Com (THAR:NASDAQ), 64.87%
- Korro Bio, Inc. (KRRO:NASDAQ), 60.81%
- TransMedics Group, Inc. (TMDX:NASDAQ), 51.18%
- PaxMedica Inc. (PXMD:NASDAQ), 47.54%
- Nuburu Inc. (BURU:NYSEMKT), 37.8%